Germany’s single-cell biotechnology sector is transforming cancer treatments by shining a light on the genetic activity of individual cells. It’s also advancing our understanding of how our immune defences respond to Covid-19.
The French and German governments are putting EUR 17.9 million into five projects aimed at using artificial intelligence to increase sustainability, identify and combat potential epidemics, and protect industry against disruptions to supply chains.
Medical technology leads the way in our bimonthly round-up of the biggest venture capital deals involving firms from Germany. But logistics, greentech and fintech companies also booked nine-figure funding rounds.
InsurTech Hub Munich (ITHM) announces the final ‘Health X Insurance’ showcase on April 6th, 15-17 CET.
A study in the journal Nature-Scientific Reports has shown that cold atmospheric plasmajet (CAP-jet) is far more salutary than the standard best-practice treatment of wounds.
Germany’s governing cabinet has drawn up contracts with five companies to deliver anti-coronavirus vaccines until 2029. The companies in question are BioNTech, Curevac/GSK, Wacker/CordenPharma, Celonic and IDT.
Belén Garijo made history in May 2021 when she became CEO of pharmaceutical giant Merck as the first non-German to head the 350-year-old company, and also the first woman to lead a DAX company on her own.
Our video looks at what makes Germany such an excellent location in the field – for the battle against Covid-19 and other deadly diseases.
Researchers at the Technical University of Munich (TUM) – together with colleagues Ludwig Maximilian University of Munich and German Research Center for Environmental Health Helmholtz Zentrum München – have made a discovery they say could be used to treat Covid-19 infections.
One of the most promising areas in the fight against cancer is so-called CAR-T therapies. At its core are genetically engineered chimeric antigen receptor T cells that allow the immune system to specifically target cancer cells.
